| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Aryeh Jason is a Director at OBIO with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $16.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 27,942 | $241.94 | $6,760,159.32 | -17.7% | |
| Mar 9, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 7,500 | $175.73 | $1,317,993.85 | -4.4% | |
| Feb 23, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 3,417 | $155.00 | $529,635.00 | -3.8% | |
| Nov 17, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 24,400 | $140.22 | $3,421,368.00 | -21.3% | |
| Aug 23, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,000 | $127.99 | $255,980.00 | -1.7% | |
| May 12, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 37,247 | $110.76 | $4,125,358.41 | -13.1% | |
| Feb 28, 2017 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 32,000 | $106.35 | $3,403,060.00 | -9.2% | |
| Nov 25, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 18,479 | $107.31 | $1,983,072.28 | -4.7% | |
| Nov 18, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 6,330 | $105.28 | $666,418.90 | -1.5% | |
| May 6, 2016 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 25,000 | $119.20 | $2,979,954.00 | -5.4% |